excellent posts catalyst … I hope the share price valuations can be reached for you …. They would be much higher IMO than the cenkos report as stock prices overshoot to the upside due to fomo and greed …. Also the valuations are based on certain project milestones and if shp management can hit the milestones for the first project , then the market will start to potentially discount the other projects. the market is still not sure if shp can hit the first milestone even though potash prices are at 8 year highs.
cenkos has just released another report about the quarterly …. I don’t think I will pay for the report via research tree but first timers can easily join for a free trial
- Forums
- ASX - By Stock
- SHP
- 7.5c SP -> $1.11 SP Target (Largest Potash Deposit in West-Europe) $30M MC
SHP
south harz potash ltd
Add to My Watchlist
25.0%
!
0.3¢

7.5c SP -> $1.11 SP Target (Largest Potash Deposit in West-Europe) $30M MC, page-5
-
-
- There are more pages in this discussion • 1,899 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.3¢ |
Change
-0.001(25.0%) |
Mkt cap ! $3.849M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.3¢ | $809 | 268.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1839138 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 5990224 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1839138 | 0.003 |
6 | 11600000 | 0.002 |
4 | 31500000 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 3990224 | 8 |
0.005 | 1301013 | 2 |
0.010 | 10000 | 1 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
Last trade - 15.59pm 04/07/2025 (20 minute delay) ? |
Featured News
SHP (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online